granules---more info

Granules India is a different company in pharma space.Granules is getting ready with timely expansion of its facilities for Pharma formulation intermediaries[PFI],Active pharma ingredients[API], Granulation and Finished dosages.Thus Granules is going to become a 'ONE STOP INTEGRATED' solution provider to major pharma companies who want to outsource some of their processes.The ongoing expansion of API and Finished Dosage facilities at Bonthapally and Gagillapur should result in sharp increase in Granules topline as well as bottomline over next few quarters.Also, the fact that promoters have recently alloted themselves fresh equity @Rs.102/-per share gives comfort about their confidence in company's future.Granules fundamentals are also quite strong.With a bookvalue of Rs.61/-,trailing EPS of Rs.6/-[estimated for 2005-2006 Rs.8/-]and a growth rate of more than 50% Granules is a safe pharma play.